{"disease":{"id":"constipation","name":"Constipation","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":24,"pipeline_drug_count":0,"trial_count":11},"drugs":{"marketed":[{"drug_id":"methylnaltrexone","indication_name":"Therapeutic opioid induced constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Relistor","generic_name":"METHYLNALTREXONE","company_name":"Salix Pharms","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":69,"revenue":"400","mechanism":"Relistor works by blocking opioid receptors in the gut to alleviate constipation."},{"drug_id":"naldemedine","indication_name":"Opioid-induced constipation (OIC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Symproic","generic_name":"NALDEMEDINE","company_name":"Bdsi","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":75,"revenue":null,"mechanism":"Symproic works by blocking the mu-type opioid receptor, which is responsible for slowing down bowel movements."},{"drug_id":"stimulant","indication_name":"Occasional constipation relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Stimulant","company_name":"Florida International University","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":9,"revenue":null,"mechanism":null},{"drug_id":"magnesium-citrate","indication_name":"Occasional constipation relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trimagnesium Dicitrate","generic_name":"MAGNESIUM CITRATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"magnesium citrate","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"medical","indication_name":"Occasional constipation relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"medical","company_name":"Assiut University","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":9,"revenue":null,"mechanism":null},{"drug_id":"medical","indication_name":"Occasional constipation relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"medical","company_name":"Assiut University","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":9,"revenue":null,"mechanism":null},{"drug_id":"tenapanor","indication_name":"Irritable Bowel Syndrome with Constipation (IBS-C)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TENAPANOR","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"prucalopride","indication_name":"Chronic Idiopathic Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PRUCALOPRIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"dehydrocholic-acid","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decholin","generic_name":"DEHYDROCHOLIC ACID","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":21,"revenue":null,"mechanism":"Decholin works by stimulating the contraction of the gallbladder and increasing bile flow."},{"drug_id":"macrogol","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miralax","generic_name":"Macrogol","company_name":"Braintree","drug_phase":"marketed","molecular_target":"","drug_class":"Osmotic Laxative [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"magnesium-oxide","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prepopik","generic_name":"MAGNESIUM OXIDE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"","drug_class":"magnesium oxide","quality_score":39,"revenue":null,"mechanism":""},{"drug_id":"azd1722","indication_name":"Irritable bowel syndrome characterized by constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ibsrela","generic_name":"AZD1722","company_name":"Ardelyx Inc","drug_phase":"marketed","molecular_target":"Sodium/hydrogen exchanger 3","drug_class":"","quality_score":55,"revenue":null,"mechanism":"Ibsrela works by inhibiting the sodium/hydrogen exchanger 3, a protein that regulates the balance of sodium and hydrogen ions in the gut."},{"drug_id":"elobixibat","indication_name":"Chronic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Goofice","generic_name":"ELOBIXIBAT","company_name":"EA Pharma","drug_phase":"discontinued","molecular_target":"Ileal sodium/bile acid cotransporter","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Goofice works by inhibiting the ileal sodium/bile acid cotransporter to stimulate bowel movements."},{"drug_id":"bisacodyl","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Halflytely","generic_name":"BISACODYL","company_name":"Braintree","drug_phase":"marketed","molecular_target":"Kappa-type opioid receptor","drug_class":"Stimulant Laxative [EPC]","quality_score":31,"revenue":null,"mechanism":""},{"drug_id":"magnesium-carbonate","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Renacidin","generic_name":"MAGNESIUM CARBONATE","company_name":"United Guardian","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"creatinine","indication_name":"flatulence associated with constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Colotox","generic_name":"CREATININE","company_name":"BioActive Nutritional, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"senna-cassia","indication_name":"constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"MBM 5 Large Intestine","generic_name":"SENNA+CASSIA","company_name":"The Wellness Center","drug_phase":"marketed","molecular_target":"","drug_class":"Copper-containing Intrauterine Device [EPC]","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"magnesium-hydroxide","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Milk of Magnesia","generic_name":"magnesium hydroxide","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Gastric acid (direct neutralization) + osmotic effect in intestine","drug_class":"Osmotic laxative, Antacid","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"cholic-acid","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cholbam","generic_name":"CHOLIC ACID","company_name":"Mirum","drug_phase":"marketed","molecular_target":"G-protein coupled bile acid receptor 1","drug_class":"Bile Acid [EPC]","quality_score":53,"revenue":null,"mechanism":"Cholbam works by binding to the G-protein coupled bile acid receptor 1, which helps regulate bile acid levels in the body."},{"drug_id":"magnesium-gluconate","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Glucomag","generic_name":"magnesium gluconate","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"magnesium gluconate","quality_score":null,"revenue":null,"mechanism":"Glucomag works by replenishing magnesium levels in the body, which helps to regulate muscle and nerve function."},{"drug_id":"linaclotide","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Linzess","generic_name":"LINACLOTIDE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Heat-stable enterotoxin receptor","drug_class":"Guanylate Cyclase-C Agonist [EPC]","quality_score":57,"revenue":null,"mechanism":"Linzess works by activating the heat-stable enterotoxin receptor to increase fluid secretion in the intestines."},{"drug_id":"linaclotide","indication_name":"Irritable bowel syndrome characterized by constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Linzess","generic_name":"LINACLOTIDE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Heat-stable enterotoxin receptor","drug_class":"Guanylate Cyclase-C Agonist [EPC]","quality_score":57,"revenue":null,"mechanism":"Linzess works by activating the heat-stable enterotoxin receptor to increase fluid secretion in the intestines."},{"drug_id":"potassium-chloride","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micro-K 10","generic_name":"POTASSIUM CHLORIDE","company_name":"Nesher Pharms","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 4","drug_class":"potassium chloride","quality_score":56,"revenue":null,"mechanism":"Micro-K 10 works by replenishing potassium levels in the body, which helps regulate muscle and nerve function."},{"drug_id":"naldemedine","indication_name":"Therapeutic opioid induced constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Symproic","generic_name":"NALDEMEDINE","company_name":"Bdsi","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":75,"revenue":null,"mechanism":"Symproic works by blocking the mu-type opioid receptor, which is responsible for slowing down bowel movements."},{"drug_id":"oxyphenisatine","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Veripaque","generic_name":"OXYPHENISATINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"oxyphenisatine","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"docusate","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Colace","generic_name":"docusate sodium","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"N/A (surfactant mechanism)","drug_class":"Stool softener (surfactant laxative)","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"sennosides","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SENNOSIDES","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"senna","indication_name":"constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Senna-S","generic_name":"SENNA","company_name":"HealthLife of USA LLC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"linzess","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Linzess","company_name":"TriHealth Inc.","drug_phase":"discontinued","molecular_target":"Heat-stable enterotoxin receptor, Heat-stable enterotoxin receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"linzess","indication_name":"Irritable bowel syndrome characterized by constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Linzess","company_name":"TriHealth Inc.","drug_phase":"discontinued","molecular_target":"Heat-stable enterotoxin receptor, Heat-stable enterotoxin receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"naltrexon","indication_name":"Therapeutic opioid induced constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naltrexon","company_name":"Institute of Liver and Biliary Sciences, India","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor subunit alpha-7, Cytochrome P450 2D6, Delta-type opioid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lactulose","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cephulac","generic_name":"LACTULOSE","company_name":"Sanwa Kagaku Kenkyusho Co., Ltd.","drug_phase":"marketed","molecular_target":"","drug_class":"Osmotic Laxative [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"sodium-phosphate-monobasic-anhydrous","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER","generic_name":"SODIUM PHOSPHATE, MONOBASIC ANHYDROUS","company_name":"OTSUKA ICU MEDCL","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 4","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"magnesium-citrate","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trimagnesium Dicitrate","generic_name":"MAGNESIUM CITRATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"magnesium citrate","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"magnesium-aspartate","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Magnesium Hydroaspartate","generic_name":"magnesium aspartate","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"magnesium aspartate","quality_score":null,"revenue":null,"mechanism":"Magnesium Hydroaspartate works by replenishing magnesium levels in the body, which helps to relax muscles and improve bowel function."},{"drug_id":"dantron","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dionone","generic_name":"dantron","company_name":"Napp Pharmaceuticals Ltd","drug_phase":"marketed","molecular_target":"Amine oxidase [flavin-containing] A","drug_class":"dantron","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"glycerine","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Glycerine","company_name":"Ferring Pharmaceuticals","drug_phase":"marketed","molecular_target":"","drug_class":"Non-Standardized Chemical Allergen [EPC]","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"movantik","indication_name":"Therapeutic opioid induced constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Movantik","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"mer","indication_name":"Temporary relief of constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mer Detox 6019","generic_name":"mer","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"lactitol","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pizensy","generic_name":"LACTITOL","company_name":"Braintree Labs","drug_phase":"marketed","molecular_target":"","drug_class":"Osmotic Laxative","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"lubiprostone","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amitiza","generic_name":"LUBIPROSTONE","company_name":"Sucampo Pharma Llc","drug_phase":"marketed","molecular_target":"Chloride channel protein 2","drug_class":"Chloride Channel Activator [EPC]","quality_score":65,"revenue":null,"mechanism":"Amitiza works by activating chloride channels in the intestines, increasing fluid secretion and promoting bowel movements."},{"drug_id":"lubiprostone","indication_name":"Irritable bowel syndrome characterized by constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amitiza","generic_name":"LUBIPROSTONE","company_name":"Sucampo Pharma Llc","drug_phase":"marketed","molecular_target":"Chloride channel protein 2","drug_class":"Chloride Channel Activator [EPC]","quality_score":65,"revenue":null,"mechanism":"Amitiza works by activating chloride channels in the intestines, increasing fluid secretion and promoting bowel movements."},{"drug_id":"tegaserod","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zelnorm","generic_name":"TEGASEROD","company_name":"","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2B","drug_class":"Serotonin-4 Receptor Agonist","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"tegaserod","indication_name":"Irritable bowel syndrome characterized by constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zelnorm","generic_name":"TEGASEROD","company_name":"","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2B","drug_class":"Serotonin-4 Receptor Agonist","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"plecanatide","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trulance","generic_name":"PLECANATIDE","company_name":"Salix","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"Guanylate Cyclase-C Agonist [EPC]","quality_score":65,"revenue":null,"mechanism":"Trulance works by stimulating the guanylate cyclase-C receptor to increase fluid secretion in the intestines."},{"drug_id":"bilirubin","indication_name":"flatulence associated with constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Colotox","generic_name":"BILIRUBIN","company_name":"BioActive Nutritional, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":""},{"drug_id":"homatropine","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Homatropin","generic_name":"homatropine","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"Cholinergic Muscarinic Antagonist","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"docusate-sodium","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Docusate","generic_name":"DOCUSATE SODIUM","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"docusate sodium","quality_score":null,"revenue":null,"mechanism":"Docusate sodium works by increasing the solubility of bile salts in the gut, allowing more water to be absorbed into the stool."},{"drug_id":"naloxegol","indication_name":"Therapeutic opioid induced constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Movantik","generic_name":"NALOXEGOL","company_name":"Averitas","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":65,"revenue":null,"mechanism":"Movantik works by blocking the mu-type opioid receptor, which is responsible for the constipating effects of opioids."},{"drug_id":"glycerol","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Glycerol","company_name":"Rutgers, The State University of New Jersey","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"mer","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mer Detox 6019","generic_name":"mer","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cholbam","indication_name":"Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cholbam","company_name":"Mirum Pharmaceuticals, Inc.","drug_phase":"marketed","molecular_target":"G-protein coupled bile acid receptor 1, Bile acid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":52,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03720613","title":"Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation","phase":"","overall_status":"RECRUITING","enrollment_count":34532,"lead_sponsor_name":"BioDelivery Sciences International","has_results":false},{"nct_id":"NCT05247333","title":"Implementation of a Minor Ailment Service in Community Pharmacy Practice","phase":"NA","overall_status":"COMPLETED","enrollment_count":20987,"lead_sponsor_name":"Universidad de Granada","has_results":false},{"nct_id":"NCT02813356","title":"Naloxegol US PMR CV Safety.","phase":"","overall_status":"UNKNOWN","enrollment_count":8800,"lead_sponsor_name":"Valinor Pharma LLC","has_results":false},{"nct_id":"NCT06755671","title":"A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms","phase":"","overall_status":"RECRUITING","enrollment_count":4500,"lead_sponsor_name":"Shanghai Hutchison Pharmaceuticals Limited","has_results":false},{"nct_id":"NCT07261826","title":"Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Chen QiYi","has_results":false},{"nct_id":"NCT04861233","title":"A Study of Lubiprostone to Treat Constipation","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Jeil Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03471728","title":"Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)","phase":"","overall_status":"COMPLETED","enrollment_count":2475,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT06695754","title":"Comparing Manual and Automatic Colonic Massage for Chronic Constipation.","phase":"","overall_status":"COMPLETED","enrollment_count":2312,"lead_sponsor_name":"usMIMA S.L.","has_results":false},{"nct_id":"NCT04918329","title":"Functional Digestive Disorders Observatory","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT03461848","title":"CYPHP Evelina London Evaluation","phase":"NA","overall_status":"COMPLETED","enrollment_count":1731,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT00765999","title":"An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1559,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT01696643","title":"Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1407,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT01965652","title":"Long Term Safety of Naldemedine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1246,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT05149833","title":"European Study of Opioid Induced Constipation","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"University of Dublin, Trinity College","has_results":false},{"nct_id":"NCT07338643","title":"The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Limian Er","has_results":false},{"nct_id":"NCT00804141","title":"Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1040,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT04350112","title":"Study of Opioid-Induced Constipation 1 Project","phase":"","overall_status":"COMPLETED","enrollment_count":1007,"lead_sponsor_name":"Royal Surrey County Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT02590432","title":"An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":828,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT00241722","title":"Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":805,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":false},{"nct_id":"NCT01186770","title":"A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":804,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT02559206","title":"Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":759,"lead_sponsor_name":"Ironwood Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04804267","title":"Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":750,"lead_sponsor_name":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07382167","title":"A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":692,"lead_sponsor_name":"Ardelyx","has_results":false},{"nct_id":"NCT05151328","title":"Efficacy and Safety of Plecanatide Comparing With Placebo in the Treatment of Functional Constipation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":648,"lead_sponsor_name":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","has_results":false},{"nct_id":"NCT03573908","title":"A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":614,"lead_sponsor_name":"Ironwood Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT02530216","title":"Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":610,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT02042183","title":"Lubiprostone in Children With Functional Constipation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":606,"lead_sponsor_name":"Sucampo Pharma Americas, LLC","has_results":true},{"nct_id":"NCT06408883","title":"Effect of Vibration Capsule on Different Subtypes of Functional Constipation","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT06877078","title":"Effect of Pre-Surgery Constipation Podcast: A RCT","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Central Jutland Regional Hospital","has_results":false},{"nct_id":"NCT01714843","title":"A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":559,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT01993940","title":"Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":553,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT03097861","title":"Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":552,"lead_sponsor_name":"Sucampo Pharma Americas, LLC","has_results":true},{"nct_id":"NCT07230821","title":"Radicle GI Health RDH™: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":550,"lead_sponsor_name":"Radicle Science","has_results":false},{"nct_id":"NCT01965158","title":"Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":547,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT04068415","title":"Development of a Constipation Risk Assessment Scale for Hospitalized Patients.","phase":"","overall_status":"COMPLETED","enrollment_count":516,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT07067957","title":"Prevalence of Functional Lower Urinary Tract Voiding Dysfunction in School-Aged Children","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT02316899","title":"Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT04460404","title":"The Predictive Value of Alarm Symptoms in Patients With Function Constipation Based on Roman IV","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Second Affiliated Hospital of Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT01880294","title":"A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia","phase":"","overall_status":"COMPLETED","enrollment_count":461,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT03150212","title":"Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype","phase":"NA","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"Lesaffre International","has_results":false},{"nct_id":"NCT04014413","title":"Safety and Efficacy of Fecal Microbiota Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04026113","title":"Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":438,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT06755424","title":"GI Symptoms in Infants Fed Goat Milk-based Infant Formula","phase":"","overall_status":"COMPLETED","enrollment_count":425,"lead_sponsor_name":"Ausnutria Hyproca B.V.","has_results":false},{"nct_id":"NCT02138136","title":"Lubiprostone for Children With Constipation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":419,"lead_sponsor_name":"Sucampo Pharma Americas, LLC","has_results":true},{"nct_id":"NCT06207721","title":"Physical Therapy for Functional Constipation in Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Delta University for Science and Technology","has_results":false},{"nct_id":"NCT02281630","title":"Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":388,"lead_sponsor_name":"Kissei Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT02425722","title":"A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":383,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT04166058","title":"Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT01147926","title":"Evaluation of Prucalopride in Male Subjects With Chronic Constipation.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":374,"lead_sponsor_name":"Shire","has_results":true}],"total":50},"guidelines":[{"drug_id":"mer","guideline_body":"FDA label","recommendation":"For the temporary relief of constipation.","line_of_therapy":"any","evidence_grade":"C","guideline_year":null}],"source":"Drug Landscape verified database"}